Showing results (241-250 of 383) with videos related to

Sort By:
Pageof 39
ACS Chemical Neuroscience|December 8, 2025
Dual Modulation of 5-HT<sub>2A</sub> Receptors and SERT by α-Ethyltryptamine and Its Optical IsomersJustin M Silverman, Michael Fiorillo, Jason Younkin, et al.
Journal of Neuropathology and Experimental Neurology|May 17, 2005
Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological agingDeng-Shun Wang, Richard B Lipton, Mindy J Katz, et al.
The American Journal of Psychiatry|April 1, 1994
Multisite data reanalysis of the validity of rapid cycling as a course modifier for bipolar disorder in DSM-IVM S Bauer, J Calabrese, D L Dunner, et al.
Journal of Alzheimer'S Disease : JAD|July 1, 2019
Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome MeasuresNobutaka Sakae, Michael G Heckman, Emily R Vargas, et al.
Acta Neuropathologica|April 27, 2016
Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk lociMariet Allen, Jeremy D Burgess, Travis Ballard, et al.
Neurobiology of Aging|March 27, 2012
Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS)Hui Shi, Olivia Belbin, Christopher Medway, et al.
Biochemical and Biophysical Research Communications|November 30, 1989
Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid proteinM R Palmert, S L Siedlak, M B Podlisny, et al.
Pflugers Archiv : European Journal of Physiology|January 19, 2016
Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cellsLia Baki, Miguel Fribourg, Jason Younkin, et al.
Neurobiology of Disease|September 25, 1998
Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-proteinM Citron, C B Eckman, T S Diehl, et al.
Pageof 39